Dominican Republic vs Lebanon: Amphetamine use disorder deaths by sex
Dominican Republic
0.12 deaths
in 2021
Lebanon
0.14 deaths
in 2021
Dominican Republic rank
110th
Lebanon rank
109th
Amphetamine use disorder deaths by sex over time
- Dominican Republic
- Lebanon
How they compare
Lebanon currently reports 0.14 deaths against 0.12 deaths in Dominican Republic, a difference of 0.02 deaths.
That makes Lebanon's figure about 1.2 times Dominican Republic's.
The two have swapped places 2 times across 22 shared years of data; in 2000 it was Lebanon ahead.
Dominican Republic ranks 110th and Lebanon ranks 109th of 194 countries.
Lebanon has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Dominican Republic | Lebanon | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 0.094 deaths | 0.158 deaths | 0.064 deaths | Lebanon |
| 2010s | 0.142 deaths | 0.17 deaths | 0.028 deaths | Lebanon |
| 2020s | 0.115 deaths | 0.155 deaths | 0.04 deaths | Lebanon |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher amphetamine use disorder deaths by sex, Dominican Republic or Lebanon?
- Lebanon, at 0.14 deaths against 0.12 deaths in Dominican Republic as of 2021.
- What is the difference in amphetamine use disorder deaths by sex between Dominican Republic and Lebanon?
- 0.02 deaths, with Lebanon ahead.
- How many years of comparable data are there for Dominican Republic and Lebanon?
- 22 years are reported by both, from 2000 to 2021.
- How do Dominican Republic and Lebanon rank globally for amphetamine use disorder deaths by sex?
- Dominican Republic ranks 110th and Lebanon ranks 109th of 194 countries.
- Where does this data come from?
- World Health Organization (2024) – with major processing by Our World in Data, published as Amphetamine use disorder deaths by sex. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Estimated number of deaths from amphetamine use disorders in females.